文献速递认知障碍与痴呆

激素替代治疗使用与痴呆风险:一项全国性队列研究

Use of Hormone Replacement Therapy and Risk of Dementia: A Nationwide Cohort Study.
PubMed 文献 · Neurology · 2022-10-24

基于台湾全国性理赔数据库的回顾性队列研究,纳入35,024名使用激素替代治疗(HRT)的女性及70,048名倾向匹配对照,随访至2013年12月31日。HRT队列痴呆累积发生率为20.04/1000,显著高于对照组的15.79/1000,校正HR为1.35(95%CI 1.13-2.62);HRT累积剂量越高,痴呆风险越高(趋势P<0.0001)。

要点

  • HRT使用与痴呆风险升高相关,校正HR为1.35(95%CI 1.13-2.62)。
  • HRT累积处方剂量越高,痴呆风险越高(趋势P<0.0001)。
  • 该研究的临床意义需进一步研究。

核心结论

  • HRT与痴呆风险升高相关。
  • 该研究的临床意义需进一步研究。

研究设计与样本

  • 回顾性队列研究,使用台湾纵向健康保险数据库的全国性理赔数据。
  • 暴露队列为35,024名使用HRT的女性,比较队列为基于倾向匹配选取的70,048名未使用HRT的女性。
  • 随访至痴呆诊断、死亡或2013年12月31日,以先发生者为准;HRT队列平均随访12.3(±2.3)年,比较队列平均随访12.2(±2.4)年。
  • 采用Cox比例风险回归模型计算风险比(HR)及95%CI。

主要发现

  • 随访期间HRT队列痴呆累积发生率为20.04/1000,显著高于比较队列的15.79/1000,校正HR为1.35(95%CI 1.13-2.62)。
  • HRT累积处方剂量越高,痴呆风险越高(趋势P<0.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Estrogen has the potential to influence brain physiology implicated in dementia pathogenesis. Hormone replacement therapy (HRT) might be expected to influence the risk of dementia. Observational data indicated that HRT was associated with reductions in dementia risk, but experimental evidence demonstrates that HRT increases the incidence of dementia. To determine the effect of HRT on the risk of dementia, a retrospective cohort study was performed using a nationwide claims dataset in Taiwan. METHODS: A population-based longitudinal study was performed using data from the Longitudinal Health Insurance Database in Taiwan. A total of 35,024 women with HRT were enrolled as the exposed cohort and 70,048 women without HRT were selected on the basis of propensity matching as the comparison cohort. All participants were followed up until the diagnosis of dementia, death, or at the end of December 31, 2013, whichever occurred first. Overall, the average duration of follow-up (±SD) in the HRT and comparison cohorts was 12.3 (±2.3) and 12.2 (±2.4), respectively. The Cox proportional hazards regression models were conducted to produce hazard ratios (HRs) with 95% CIs to evaluate the association of HRT with the risk of dementia. RESULTS: In the follow-up period, the cumulative incidence of dementia for the HRT cohort (20.04 per 1,000) was significantly higher than the corresponding cumulative incidence for the comparison cohort (15.79 per 1,000), resulting in an adjusted HR of 1.35 (95% CI 1.13-2.62). There was an increased risk of dementia with a higher cumulative dose of HRT prescription (p for trend <0.0001). DISCUSSION: This cohort study documented that HRT was associated with an increased risk of dementia. The clinical implications of this study merit further investigations.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Sung YF, Tsai CT, Kuo CY, et al. Use of Hormone Replacement Therapy and Risk of Dementia: A Nationwide Cohort Study. Neurology. 2022. PMID: 36240091. doi:10.1212/WNL.0000000000200960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。